Quotient Sciences, a global pharmaceutical drug development and manufacturing accelerator, appointed Thierry Van Nieuwenhove as its new chief executive officer. Thierry succeeds Mark Egerton who is retiring after 18 as CEO. As part of the leadership transition, the company named Wayne Hewett non-executive chairman. Nieuwenhove joins Quotient with an extensive track record in the pharma and CDMO services industry spanning over 23 years, and with experience in both small molecules and biolog...